Faculty: Rafael Sanchez-Salas, Steve Scionti & Cary Robertson
Moderators: Clint Bahler & Tom Polascik
Rafael Ernesto Sanchez-Salas
Rafael Sanchez Salas in a Franco-Venezuelan Urologic Surgeon born in Mérida-Venezuela. He received his medical degree from the Universidad de los Andes in Mérida-Venezuela in 1998 with a Magna laude diploma and the first place of his class rank. Subsequently, he obtained degrees in General surgery and Urology from the Universidad Central de Venezuela, both at the University Hospital of Caracas. He followed with a Fellowship research on Urologic oncology at Memorial Sloan Kettering Cancer Center and clinical fellowships of Endourology and Advanced Laparoscopic Surgery and Urological Robotic Surgery at the Santa María Clinic in Santiago, Chile and at the Institut Mutualiste Montsouris in Paris,France, respectively. At the end of his training period in Paris, he joined the Department of Urology team at the Institut Mutualiste Montsouris, where he is currently an Attending Surgeon. He holds French State Diplomas in Clinical Oncology and Urological Oncology. He sits on several international Urological Boards and serves as reviewer for major Urological journals. Dr. Sanchez-Salas career is characterized by sustained work with academic orientation.
Dr Cary N. Robertson is Associate Professor of Urology, Department of Surgery specializing in Urologic Oncology. A medical graduate of Tulane Medical School, he completed surgical internship at the University of Oregon Health Sciences Center in 1978 and served in the US Public Health Service National Health Service Corps 1978-1980. He completed surgical training in Urology at Duke University Medical Center in 1985, followed by completion of a Urologic Oncology fellowship at NCI/NIH in 1987. He served as a Senior Investigator, National Cancer Institute, National Institutes of Health 1987-1988 and joined the surgical faculty of Duke University Medical Center, Division of Urology, Department of Surgery in 1988. He is a member of the Duke Cancer Institute serving as Associate Director, Urologic Oncology, specializing in the treatment of genitourinary malignancies. He utilizes robotic techniques in the surgical management of prostate cancer and renal tumors. He has been active in clinical trials of prostate, bladder and renal cancers. As National Coordinating Principal Investigator for the North American ENLIGHT Ablatherm High Intensity Focused Ultrasound (HIFU) Clinical Trial he pioneered this novel therapy for the management of localized prostate cancer. As Director, Morris Center for Urologic Research, he supports basic research in prostate cancer. Combination approaches utilizing HIFU and immunotherapy are under study in collaboration with the Duke University Department of Biomedical Engineering. As a co-founder of the Duke Prostate Center Multi-Disciplinary Genitourinary Clinic, he consults with colleagues for multi-modal therapeutic approaches to GU cancers. He served as Director, Annual Prostate Cancer Screening Clinic 1990 - 2011. He currently serves as Associate Director, Urologic Oncology, Duke Cancer Institute and Staff Physician in Urology, Durham VA Medical Center, Durham, NC. He is past president, North Carolina Urological Association and is a member of the Society of Urologic Oncology, American Urological Association, European Association of Urology, Society of Endourology, American Society of Clinical Oncology, American Medical Association, North Carolina Medical Association and the American College of Surgeons.
Clint Bahler, M.D.
Assistant Professor, Urology
Adjunct Assitant Professor, Radiology and Imaging Sciences
Indiana University School of Medicine
Dr. Clint Bahler completed his urology residency at Indiana University School of Medicine and chose to undergo additional specialty fellowship training in laparoscopic and robotic surgery with Dr. Chandru Sundaram at IU School of Medicine. His areas of clinical interest are prostate cancer and kidney cancer. Dr. Bahler enjoys bringing medical advances to patients and is currently a principle investigator for clinical trials testing advanced PSMA-PET imaging to guide robotic prostatectomy as well as High Intensity Focused Ultrasound (HIFU).